Both ALKBH5 and ALKBH2 are highly expressed in glioblastoma and this is the reason why we started our experimental validation from these two proteins, while an in-depth analysis and validations for the other top-ranked potential targets will be the matter of future studies. The gene discussed is ALKBH2; the disease is glioblastoma.